Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.
about
Acute Kidney Injury and Progression of Diabetic Kidney Disease.Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic miceAstragaloside IV represses high glucose-induced mesangial cells activation by enhancing autophagy via SIRT1 deacetylation of NF-κB p65 subunitAstragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats
P2860
Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Astragaloside IV protects agai ...... -induced diabetic nephropathy.
@en
type
label
Astragaloside IV protects agai ...... -induced diabetic nephropathy.
@en
prefLabel
Astragaloside IV protects agai ...... -induced diabetic nephropathy.
@en
P2093
P2860
P1433
P1476
Astragaloside IV protects agai ...... -induced diabetic nephropathy.
@en
P2093
Hengjiang Guo
Xuemei Zhang
Yang Zhang
Yingjun Zang
Yunman Wang
P2860
P2888
P356
10.1038/S41598-017-07061-7
P407
P50
P577
2017-07-31T00:00:00Z
P6179
1090928911